(VIANEWS) – NEXTENSA (NEXTA.BR), IBA (IBAB.BR), CHRISTIAN DIOR (CDI.PA) are the highest payout ratio stocks on this list.
We have gathered information regarding stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. NEXTENSA (NEXTA.BR)
105.49% Payout Ratio
Nextensa is a mixed-use real estate investor and developer. The company's investment portfolio is divided between the Grand Duchy of Luxembourg (43%), Belgium (42%) and Austria (15%); its total value as at 31/12/2023 was approximately € 1.3 billion. As a developer, Nextensa is primarily active in shaping large urban developments. At Tour & Taxis (development of over 350,000 sqm) in Brussels, Nextensa is building a mixed real estate portfolio consisting of a revaluation of iconic buildings and new constructions. In Luxembourg (Cloche d'Or), it is working in partnership on a major urban extension of more than 400,000 sqm consisting of offices, retail and residential buildings. The company is listed on Euronext Brussels and has a market capitalisation of € 488.6 M (value 31/12/2023).
Earnings Per Share
As for profitability, NEXTENSA has a trailing twelve months EPS of €2.47.
PE Ratio
NEXTENSA has a trailing twelve months price to earnings ratio of 17.37. Meaning, the purchaser of the share is investing €17.37 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.86%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 39.8%, now sitting on 120.11M for the twelve trailing months.
More news about NEXTENSA.
2. IBA (IBAB.BR)
94.67% Payout Ratio
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Earnings Per Share
As for profitability, IBA has a trailing twelve months EPS of €-0.31.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.2%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.9%, now sitting on 428.72M for the twelve trailing months.
Volume
Today’s last reported volume for IBA is 5925 which is 76.2% below its average volume of 24899.
Yearly Top and Bottom Value
IBA’s stock is valued at €12.74 at 17:10 EST, way under its 52-week high of €15.20 and way above its 52-week low of €8.26.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 27, 2024, the estimated forward annual dividend rate is 0.17 and the estimated forward annual dividend yield is 1.35%.
More news about IBA.
3. CHRISTIAN DIOR (CDI.PA)
35.79% Payout Ratio
Christian Dior SE, through its subsidiaries, engages in the production, distribution, and retail of fashion and leather goods, wines and spirits, perfumes and cosmetics, and watches and jewelry worldwide. The company offers its fashion and leather goods under the Louis Vuitton, Fendi, Celine, Loewe, Givenchy, Kenzo, Berluti, Pucci, Loro Piana, Rimowa, and Off-White brand names; and wines and spirits under the Hennessy, Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Château d'Yquem, Belvedere, Glenmorangie, Newton Vineyards, Bodega Numanthia, Château d'Esclans, Armand de Brignac, and Joseph Phelps brands. It also provides perfumes and cosmetics under the Parfums Christian Dior, Guerlain, Parfums Givenchy, Make Up For Ever, Benefit Cosmetics, Fresh, Acqua di Parma, KVD Vegan Beauty, Fenty, Ole Henriksen, Maison Francis Kurkdjian, and Officine Universelle Buly 1803 brand names; and watches and jewelry under the Tiffany, Bulgari, TAG Heuer, Zenith, Hublot, Chaumet, Fred, and Repossi brands. In addition, the company operates retail stores under the DFS Galleria, Sephora, and Le Bon Marché names; publishes Le Parisien-Aujourd'hui en France, a daily newspaper; builds yachts; and operates hotel and the Cova pastry shop brand. Further, it is involved in real estate activities. The company sells its products through store network, including e-commerce websites; and agents and distributors. The company was incorporated in 1946 and is headquartered in Paris, France. Christian Dior SE (ENXTPA:CDI) operates as a subsidiary of Financière Agache Société Anonyme.
Earnings Per Share
As for profitability, CHRISTIAN DIOR has a trailing twelve months EPS of €36.71.
PE Ratio
CHRISTIAN DIOR has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.78%.
Volume
Today’s last reported volume for CHRISTIAN DIOR is 2812 which is 40.71% below its average volume of 4743.
Moving Average
CHRISTIAN DIOR’s value is way above its 50-day moving average of €700.92 and higher than its 200-day moving average of €713.77.
More news about CHRISTIAN DIOR.
4. CRCAM ATL.VEND.CCI (CRAV.PA)
34.35% Payout Ratio
Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée provides banking products and services in France. It offers accounts and card services; real estate, personal, credit consolidation, student, work, housing transition, and vehicle loans; saving products; revolving credit; and life, home, car and 2-wheeler, health and welfare, leisure and daily, and borrower insurance products. The company also provides real estate investment, mobile payment, cash management, collection and payment, funding, trade and export financing, international solutions, financial engineering, and advisory services, as well as retirement saving solutions. It serves individuals, private banks, businesses, professionals, farmers, public community and social housing, and associations. The company was incorporated in 2001 and is headquartered in Nantes, France. Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée is a subsidiary of Crédit Agricole S.A.
Earnings Per Share
As for profitability, CRCAM ATL.VEND.CCI has a trailing twelve months EPS of €13.62.
PE Ratio
CRCAM ATL.VEND.CCI has a trailing twelve months price to earnings ratio of 5.92. Meaning, the purchaser of the share is investing €5.92 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.37%.
More news about CRCAM ATL.VEND.CCI.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
Sales Growth
1’s sales growth is 1% for the present quarter and 1% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).
More news about 1.
